Kaydan Wealth Management’s Zymergen Inc. Common Stock ZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-11,930
Closed -$33.2K 89
2022
Q3
$33.2K Sell
11,930
-3,384
-22% -$8.21K 0.02% 84
2022
Q2
$18.8K Buy
+15,314
New +$25.7K 0.01% 91

Kaydan Wealth Management's ZY Position: Q4 2022 in Review

Kaydan Wealth Management sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 11,930 shares — an estimated $33.2K sold.

Kaydan Wealth Management first reported a position in ZY in Q2 2022 and held it in 2 quarters. The position peaked at $33.2K in Q3 2022. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

  • Kaydan Wealth Management reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Kaydan Wealth Management sold 11,930 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $33.2K.
  • Kaydan Wealth Management first reported a position in Zymergen Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • Kaydan Wealth Management's Zymergen Inc. Common Stock position peaked at $33.2K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on Kaydan Wealth Management's 13F filing for Q4 2022, filed 6 Feb 2023.